» Articles » PMID: 20185818

Epidemiology of Cardio-renal Syndromes: Workgroup Statements from the 7th ADQI Consensus Conference

Citing Articles

Butyrate-Mediated Modulation of Paraoxonase-1 Alleviates Cardiorenometabolic Abnormalities in a Rat Model of Polycystic Ovarian Syndrome.

Olaniyi K, Areloegbe S, Badejogbin O, Ajadi I, Ajadi M Cardiovasc Drugs Ther. 2024; .

PMID: 39549177 DOI: 10.1007/s10557-024-07649-y.


Biomarkers in cardiorenal syndrome, a potential use in precision medicine.

Stefanou E, Tountas C, Ioannidis E, Kole C J Nephrol. 2024; 37(8):2127-2138.

PMID: 39153147 DOI: 10.1007/s40620-024-02047-x.


The Need to Identify Novel Markers for Early Renal Injury in Cardiorenal Syndrome.

Lisa A, Carbone F, Liberale L, Montecucco F Cells. 2024; 13(15.

PMID: 39120314 PMC: 11311518. DOI: 10.3390/cells13151283.


Efficacy of CHADS-VASc scores in predicting chronic kidney disease risk in patients treated in cardiac intensive care units.

Sakaguchi E, Naruse H, Ishihara Y, Hattori H, Yamada A, Kawai H Heliyon. 2024; 10(13):e32452.

PMID: 39044981 PMC: 11263721. DOI: 10.1016/j.heliyon.2024.e32452.


Prevention of Heart Failure in Patients with Chronic Kidney Disease.

Raghban A, Kirsop J, Tang W Curr Cardiovasc Risk Rep. 2024; 9(1).

PMID: 38993263 PMC: 11238633. DOI: 10.1007/s12170-014-0428-z.